2-es típusú cukorbetegség: vizsgálatok itt: Németország
62 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in NémetországKHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
- Where
- Munich
- Életkor
- 18 év to 64 év
- People
- 220 worldwide
- Run by
- Khondrion BV
See details and how to joinNCT06451757 · EU 2025-522361-30-00 - 3. fázisTaking peopleEfficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
- Where
- Berlin, Essen, Hanover
- Életkor
- 18 év and over
- People
- 549 worldwide
- Run by
- Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bad Oeynhausen, Bochum, Cologne, Dresden, Falkensee, Gera, Hamburg, Leipzig, Lübeck, Mainz, Mannheim, München, Münster, Nuremberg, Obertshausen, Oldenburg, Stuttgart, Ulm, Wangen, Würzburg
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleA Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
- Where
- Berlin, Bochum, Bünde, Dresden, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Offenbach Am Main, Schwerin
- Életkor
- 18 év and over
- People
- 420 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524616-11-00 - No phaseTaking peopleLIfestyle MEtabotype Study A
- Where
- Potsdam
- Életkor
- 40 év to 75 év
- People
- 300
- Run by
- German Institute of Human Nutrition
See details and how to joinNCT07868601 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Amberg, Bad Oeynhausen, Berlin, Bochum, Bünde, Essen, Hof, Mannheim
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00 - No phaseTaking peoplePrecise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes
- Where
- Nuthetal
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- German Institute of Human Nutrition
See details and how to joinNCT07171281 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Dresden, Duisburg, Essen, Hamburg, Köln, Leipzig, Lingen, Mainz, Mannheim, Oldenburg in Holstein, Wangen im Allgäu
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - 1. fázisTaking peopleAn Open-Label, Controlled, Multiple-Dose Phase I Clinical Trial Evaluating the Steady-State Pharmacokinetics, Pharmacodynamics and Safety of SHR-3167 in Subjects With Type 2 Diabetes
- Where
- Neuss
- Életkor
- 18 év and over
- People
- 35
- Run by
- Jiangsu Hengrui Pharmaceuticals Co. Ltd.
See details and how to join2026-525932-40-00 - 3. fázisNot yet taking people in NémetországA Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Where
- Berlin, Essen, Hanover
- Életkor
- 18 év and over
- People
- 1560 worldwide
- Run by
- Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743450 - 1/2. fázisTaking peopleA Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D
- Where
- Neuss
- Életkor
- 18 év to 75 év
- People
- 188
- Run by
- Gubra A/S
See details and how to joinNCT07702890 · EU 2025-524921-42-00 - 3. fázisTaking peopleA trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
- Where
- Bad Oeynhausen, Bochum, Cologne, Dresden, Falkensee, Gera, Hamburg, Köln, Leipzig, Luebeck, Mainz, Mannheim, Muenster, München, Nürnberg, Obertshausen, Oldenburg in Holstein, Stuttgart, Ulm, Wangen im Allgäu, Wuerzburg
- Életkor
- 18 év and over
- People
- 1010 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524688-19-00 - 3. fázisNot yet taking people in NémetországStudy of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
- Where
- Berlin, Offenbach Am Main
- Életkor
- 18 év and over
- People
- 760 worldwide
- Run by
- Tecnimede-Sociedade Tecnico-Medicinal S.A.
See details and how to join2025-524606-15-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Bad Oeynhausen, Berlin, Chemnitz, Duisburg, Erlangen, Frankfurt am Main, Hamburg, Heilbronn, Hohenmölsen, Ludwigshafen, Münster, Nittendorf, Obertshausen, Pirna, St Ingbert, Stuttgart
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 3. fázisTaking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Dresden
- Életkor
- 18 év to 65 év
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - 3. fázisNot yet taking people in NémetországAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Deggingen, Essen, Gelnhausen, Hamburg, Hohenmölsen, Jerichow, Leipzig, Ratingen
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - No phaseTaking peopleINNODIA Family & Friends Early-Stage T1D Detection Protocol
- Where
- Greifswald
- Életkor
- 1 év to 45 év
- People
- 30 000 worldwide
- Run by
- INNODIA iVZW
See details and how to joinNCT07118098 - 4. fázisNot yet taking people in NémetországA Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
- Where
- Amberg, Bad Mergentheim, Bad Reichenhall, Berlin, Bünde, Daaden, Dortmund, Dresden, Duisburg, Eisenach, Essen, Fulda, Hamburg, Hof, Jerichow, Leipzig, Lichtenfels, Ludwigsburg, Osnabrück, Pohlheim, Singen (Hohentwiel), Trier
- Életkor
- 18 év and over
- People
- 586 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07112339 · EU 2024-520068-32-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Where
- Amberg, Bad Oeynhausen, Berlin, Duisburg, Eisenach, Elsterwerda, Falkensee, Frankfurt am Main, Gladbeck, Hamburg, Magdeburg, Mannheim, Münster, Nittendorf, Obertshausen, Oldenburg in Holstein, Pirna
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00 - 1. fázisTaking peopleA Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes
- Where
- Neuss
- Életkor
- 18 év to 64 év
- People
- 60
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07270731 · EU 2024-519382-22-00 - 1. fázisTaking peopleA Double-blind, Placebo-controlled, Multiple-Dose, 2-Period Crossover Study to Evaluate the Effect of Steady-state AZD6793 on the Steady-state Pharmacokinetics/Pharmacodynamics of Metformin in Participants with Type 2 Diabetes Mellitus
- Where
- Neuss
- Életkor
- 18 év and over
- People
- 35
- Run by
- AstraZeneca AB
See details and how to join2025-522551-25-00 - 1. fázisTaking peopleInvestigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
- Where
- Neuss
- Életkor
- 18 év to 75 év
- People
- 80
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07535307 · EU 2025-521595-55-00 - 2. fázisTaking peopleDapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
- Where
- Duesseldorf
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- Marc Donath
See details and how to joinNCT06047262 · EU 2024-511828-14-00 - No phaseTaking peopleDisentangling the Effect of Brain Insulin Resistance on Brain Health
- Where
- Ulm
- Életkor
- 50 év to 80 év
- People
- 150 worldwide
- Run by
- Henrik Bo Wiberg Larsson
See details and how to joinNCT07374705 - No phaseTaking peopleMitochondrial Substrate Utilization in the Diabetic Human Heart
- Where
- Düsseldorf
- Életkor
- 20 év to 85 év
- People
- 500
- Run by
- Heinrich-Heine University, Duesseldorf
See details and how to joinNCT05958706